Drugs / RNA-transfected mature autologous DC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01216436 | Jan 2010 → Oct 2013 | metastatic melanoma | Duke University | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RNA-transfected mature autologous DC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01216436 ↗ |
| Modality | Cell therapy | “Dendritic cells (DC) will be administered” NCT01216436 ↗ |
| Route | Other | “by intranodal injection under ultrasound guidance” NCT01216436 ↗ |